HomeMarketsSharesBLACKROCK WORLD MINING TRUST PL

Trade BLACKROCK WORLD MINING TRUST PL - BRWM CFD

Market is not available at the momentMarket information is presented
as of 2026-10-05T15:27:53+00:00
Trading Conditions
Type
This financial market is available for CFD trading.
Learn more about:CFDs
CFD
Spread0.079
Long position overnight funding adjustment
Long position overnight funding adjustment

Margin. Your investment
£1,000.00
Overnight funding adjustment
Charges from full value of position
-0.021276 %
(-£4.26)

Trade size with leverage ~ £20,000.00

Money from leverage ~ $£19,000.00


-0.02128%
Short position overnight funding adjustment
Short position overnight funding adjustment

Margin. Your investment
£1,000.00
Overnight funding adjustment
Charges from full value of position
-0.000642 %
(-£0.13)

Trade size with leverage ~ £20,000.00

Money from leverage ~ $£19,000.00


-0.00064%
Overnight funding adjustment time21:00 (UTC)
CurrencyGBP
Min traded quantity1
Margin5.00%
Stock exchangeGreat Britain
Commission on trade10%
Guaranteed stop premium
A guaranteed stop-loss (GSL) fee is only charged if the GSL is triggered. Please consult the Charges and Fees section of our website for more details.
1%

1Our charge for executing your trade is the spread, the difference between the buy and sell price. Please consult the Charges and Fees section of our website for further information

Key Stats
Prev. Close9.4005
Open9.47
1-Year Change40.23%
Day's Range9.3805 - 9.54

Trade BLACKROCK WORLD MINING TRUST PL - BRWM

About BlackRock World Mining Trust Plc

BlackRock World Mining Trust plc is a United Kingdom-based investment company. The Company's investment objective is to provide a diversified investment in mining and metal assets worldwide, actively managed with the objective of maximizing total returns. The Company principally invests in quoted securities. The Company’s investment policy includes investing in royalties derived from the production of metals and minerals as well as physical metals. The Company holds approximately 10% of its gross assets in physical metals and invests approximately 20% in unquoted investments. The Company's subsidiary, BlackRock World Mining Investment Company Limited, is engaged in investment dealing. The Company's alternative investment fund manager is BlackRock Fund Managers Limited.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, BlackRock World Mining Trust Plc revenues decreased 8% to £208.4M. Net income decreased 11% to £192.5M. Revenues reflect Net Loss - Fin. Instruments Fair Value decrease of 33% to £122.4M, Net profit/ (loss) on foreign exchange - decrease from £2.4M to -£1.7M, Option premium income decrease of 19% to £7.1M.

Equity composition

04/2008, Company name changed from Merrill Lynch World Mining Trust plc.

Latest shares articles

BNP Paribas stock forecast
BNP Paribas stock forecast: Q2 earnings beat estimates
BNP Paribas is a French banking group whose recent developments include a Swift ledger transaction with HSBC for Siemens and continued focus on eurozone interest rates. Explore third-party BNP price targets and technical analysis. Past performance is not a reliable indicator of future results.
7 hours ago
Boeing stock forecast
Boeing stock forecast: FAA investigates Miami freighter crash
Boeing is a US aerospace manufacturer whose shares remain in focus after a 767-300 freighter crash in Miami prompted an FAA investigation. Explore third-party BA price targets and technical analysis. Past performance is not a reliable indicator of future results.
8 hours ago
CaixaBank stock forecast
CaixaBank stock forecast: BPI exits Angola market
CaixaBank is a Spanish bank whose Portuguese unit, Banco BPI, agreed to sell its 33.35% stake in Banco de Fomento de Angola for €388.5m. Explore third-party CABK price targets and technical analysis. Past performance is not a reliable indicator of future results.
9 hours ago
Valneva stock forecast
Valneva stock forecast: EMA validates Lyme vaccine application
Valneva is a French vaccine company listed on Euronext Paris. In August, the EMA validated the marketing-authorisation application for its Lyme disease vaccine candidate with Pfizer. Explore third-party VLA price targets. Past performance is not a reliable indicator of future results.
12 hours ago

User feedback and ratings

Showing our 4 & 5 star reviews. The specific details of the user have been intentionally anonymised to safeguard their privacy pursuant to GDPR requirements.

Ready to join a leading broker?

1. Create your account2. Make your first deposit3. Start when you’re ready